TipRanks
Advertisement
Advertisement

ALLR Stock Latest News

Valion Bio outlines perspectives of new Board Chair Jensen
The FlyValion Bio outlines perspectives of new Board Chair Jensen
13d ago
ALLR
VBIO
Allarity updates on recent advances in Drug Response Predictor technology
PremiumThe Fly
Allarity updates on recent advances in Drug Response Predictor technology
18d ago
ALLR
Allarity expands lab capabilities to include proteomics, cell line research
PremiumThe Fly
Allarity expands lab capabilities to include proteomics, cell line research
20d ago
ALLR
Valion Bio appoints CFO Lisa Wolf as president, COO
PremiumThe Fly
Valion Bio appoints CFO Lisa Wolf as president, COO
2M ago
ALLR
VBIO
Allarity Wins Key U.S. Patent for Stenoparib Diagnostic
PremiumCompany Announcements
Allarity Wins Key U.S. Patent for Stenoparib Diagnostic
4M ago
8K
ALLR
Allarity to present trial-in-progress poster on Phase 2 stenoparib trial
PremiumThe FlyAllarity to present trial-in-progress poster on Phase 2 stenoparib trial
4M ago
ALLR
Allarity Therapeutics Updates CEO Management and Compensation Agreement
Premium
Company Announcements
Allarity Therapeutics Updates CEO Management and Compensation Agreement
5M ago
8K
ALLR
Allarity Highlights Stenoparib Progress in New Investor Presentation
Premium
Company Announcements
Allarity Highlights Stenoparib Progress in New Investor Presentation
5M ago
8K
ALLR
Allarity receives notice of allowance from USPTO
PremiumThe Fly
Allarity receives notice of allowance from USPTO
6M ago
ALLR
Allarity’s Terminated Breast Cancer Trial Signals Setback for DRP-Guided Chemotherapy
PremiumCompany Announcements
Allarity’s Terminated Breast Cancer Trial Signals Setback for DRP-Guided Chemotherapy
7M ago
ALLR
Allarity Therapeutics Secures $20 Million Structured Note Financing
PremiumCompany Announcements
Allarity Therapeutics Secures $20 Million Structured Note Financing
8M ago
8K
ALLR
Allarity closes $20M financing for stenoparib advancement
PremiumThe Fly
Allarity closes $20M financing for stenoparib advancement
8M ago
ALLR
Allarity doses first patients in Phase 2 trial of SCLC
PremiumThe FlyAllarity doses first patients in Phase 2 trial of SCLC
8M ago
ALLR
Allarity announce enrollment open for Phase 2 trial of stenoparib, temozolomide
Premium
The Fly
Allarity announce enrollment open for Phase 2 trial of stenoparib, temozolomide
9M ago
ALLR
Allarity Therapeutics Secures Flexible Equity Financing Facility
Premium
Company Announcements
Allarity Therapeutics Secures Flexible Equity Financing Facility
9M ago
8K
ALLR
Allarity CEO says 2026 represents an ‘inflection point’
PremiumThe Fly
Allarity CEO says 2026 represents an ‘inflection point’
10M ago
ALLR
Allarity Therapeutics Completes Additional Private Equity Financing
PremiumCompany Announcements
Allarity Therapeutics Completes Additional Private Equity Financing
10M ago
8K
ALLR
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO
PremiumCompany Announcements
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO
10M ago
8K
ALLR
Allarity files $50M mixed securities shelf
PremiumThe Fly
Allarity files $50M mixed securities shelf
11M ago
ALLR
Allarity reports Q3 EPS (19c) vs ($7.71) last year
PremiumThe FlyAllarity reports Q3 EPS (19c) vs ($7.71) last year
11M ago
ALLR
ALLR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ALLR Earnings this Week: How Will it Perform?
11M ago
ALLR
Allarity Therapeutics Advances Ovarian Cancer Study with 2X-121
Premium
Company Announcements
Allarity Therapeutics Advances Ovarian Cancer Study with 2X-121
12M ago
ALLR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >